Literature DB >> 17446342

Unexpected failure of anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease.

Peter J Barnes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17446342     DOI： 10.1164/rccm.200702-253ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  12 in total

Review 1.  Anti-TNFα therapy in inflammatory lung diseases.

Authors:  Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

2.  Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities.

Authors:  Nicola J Sinden; Robert A Stockley
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

Review 3.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

Review 4.  Influencing the decline of lung function in COPD: use of pharmacotherapy.

Authors:  Ekaterina S Gladysheva; Atul Malhotra; Robert L Owens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

5.  Tobacco smoke induced COPD/emphysema in the animal model-are we all on the same page?

Authors:  Maike Leberl; Adelheid Kratzer; Laimute Taraseviciene-Stewart
Journal:  Front Physiol       Date:  2013-05-15       Impact factor: 4.566

6.  Cytokines in chronic respiratory diseases.

Authors:  Sergei P Atamas; Svetlana P Chapoval; Achsah D Keegan
Journal:  F1000 Biol Rep       Date:  2013-02-01

7.  Association of Elevated Serum GM-CSF, IFN-γ, IL-4, and TNF-α Concentration with Tobacco Smoke Induced Chronic Obstructive Pulmonary Disease in a South Indian Population.

Authors:  Ankita Mitra; Sangeetha Vishweswaraiah; Tania Ahalya Thimraj; Mahendra Maheswarappa; Chaya Sindaghatta Krishnarao; Komarla Sundararaja Lokesh; Jayaraj Biligere Siddaiah; Koustav Ganguly; Mahesh Padukudru Anand
Journal:  Int J Inflam       Date:  2018-08-01

8.  Relationships of Haptoglobin Phenotypes with Systemic Inflammation and the Severity of Chronic Obstructive Pulmonary Disease.

Authors:  Pao-Lin Lee; Kang-Yun Lee; Tsai-Mu Cheng; Hsiao-Chi Chuang; Sheng-Ming Wu; Po-Hao Feng; Wen-Te Liu; Kuan-Yuan Chen; Shu-Chuan Ho
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

9.  Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice.

Authors:  Sophia P Karabela; Chrysoula A Kairi; Sophia Magkouta; Ioannis Psallidas; Charalampos Moschos; Ioannis Stathopoulos; Spyros G Zakynthinos; Charis Roussos; Ioannis Kalomenidis; Georgios T Stathopoulos
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

10.  Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study.

Authors:  Jooyoung Lee; Jong Pil Im; Kyungdo Han; Seona Park; Hosim Soh; Kukhwan Choi; Jihye Kim; Jaeyoung Chun; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2019-11-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.